SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Provectus Pharmaceuticals Inc. -- Ignore unavailable to you. Want to Upgrade?

To: SG who wrote (11729)1/18/2013 8:10:53 AM
From: NTTG1 Recommendation  Read Replies (1) | Respond to of 13111
 
Hey SG, an unfortunate but understandable decision. I wish you well in the future.

I have to admit that in all the years I have followed small start up companies, PVCT tops the list for shameless pumping on multiple message boards and blogs. PVCT performance and track record has far underperformed the industry, while MGT salaries have topped the category. Blame falls squarely on MGT and the BOD for performance, a select few for pumping, and those who did not step in to curtail pumping activities when they had the opportunity.

Investing in early biotech is an admitted long shot in most cases, but PVCT really has been something else



To: SG who wrote (11729)1/21/2013 11:16:44 AM
From: pincus  Read Replies (1) | Respond to of 13111
 
Everyone--including the company--should read this post exactly for what it is: a long time supporter of this stock got fed up with the anemic progress and booked. Years of hearing how this quarter or next quarter was going to be the One led to the ultimate frustration of losing faith. Yep, losing faith in the people who run this company.

To spin this any other way is unproductive.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News